Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

MIRECC / CoE

Menu
Menu
Quick Links
Veterans Crisis Line Badge
My healthevet badge
 

Webinar Series



NEXT UP: January 8th, 2024 at 12-1PM

Early Detection and Treatment of Psychosis During the Transition from Active Duty to Civilian Life

with Eric Nelson, MD


Purpose Statement:

The peak age of incidence of schizophrenia and other psychotic disorders overlaps significantly with the age range of the 175,000 US Service members transitioning from active duty to civilian life annually, but there is no program to detect psychosis during this transition when many are between sources of health care. Delays in identification and treatment produce worse outcomes, contributing to the massive $1.5 million lifetime fiscal cost to the government per person living with schizophrenia. Prompt identification and treatment has the advantage of reducing the duration of untreated psychosis, improving outcomes. The purpose of this live, knowledge-based virtual presentation for inter-professional healthcare teams will cover the identification and treatment of those with or at risk for psychosis.

Outcome/Objectives:
At the conclusion of this educational program, learners will be able to:
1. describe psychosis risk states and their associated symptoms;
2. describe and characterize 2 evidence-based interventions that improve long-term
outcomes in schizophrenia; and
3. identify 3 important risk factors to consider with patients with psychosis.

Program Description: 
The VISN 2 Mental Illness Research, Education and Clinical Centers (MIRECC) pursues a discovery-to-recovery approach to determine the causes, identify predictors, and develop treatments for individuals with SMI, with emphasis on psychosis and on suicide. The topics for this series consist of innovative treatments that we have created/tested and insights from research that have helped to inform clinical care.

Target Audience:
Physicians, Psychologists, Social Workers, Nurses, Counselors, and Therapists

Accreditations (1 CE): ACCME, ACCME-NP, APA, ASWB, JA IPCE, NBCC, NYSED SW, NYSED Psychology

Registration:
VA Providers (TMS #131014486)
Non-VA Providers (TRAIN #1125538)

PRESENTER:

Eric Nelson, MDEric Nelson, M.D., is a licensed psychiatrist and a VA Advanced Fellow in Mental Illness Research and Treatment at the James J. Peters VA Medical Center in Bronx, NY. Having served as a US Army infantry officer including in combat in Iraq and Afghanistan before going to medical school as a civilian, Dr. Nelson graduated with honors for distinction in research. In residency, he was primary author of several peer-reviewed publications and was awarded the Psychiatry Residency Training Program Award for Research. During his current fellowship at the VISN 2 MIRECC in New York, Dr. Nelson has been a study clinician in a program for Veterans transitioning from active duty to civilian life, and he is currently working on implementation of psychosis screening, evaluation, and treatment for that population.








Additional Information for TMS Registration:
Register Now instead of Assign in TMS
Questions?
Non-VA employees, please contact the VHA TRAIN Help Desk by email at VHATRAIN@va.gov.
VA employees, please contact Lauran Hardy at Lauran.Hardy@va.gov


Last updated: December 31, 2024
 

VISN 2 MIRECC Menu